AIM
EXAS

Acrospire Investment Management’s Exact Sciences EXAS Stock Holding History

Acrospire Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,160
Closed -$41K – 490
2017
Q2 		$41K Buy
1,160
+200
+21% +$6.17K 0.04% 1043
2017
Q1 		$23K Buy
+960
New +$19K 0.02% 1540

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Acrospire Investment Management's EXAS Position: Q3 2017 in Review

Acrospire Investment Management sold out of Exact Sciences (EXAS) in Q3 2017, closing a stake of 1,160 shares — an estimated $41K sold.

Acrospire Investment Management first reported a position in EXAS in Q1 2017 and held it in 2 quarters. The position peaked at $41K in Q2 2017. 282 funds tracked by Wall St. Rank hold EXAS as of Q3 2017.

  • Acrospire Investment Management reported no remaining Exact Sciences position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,160 Exact Sciences shares in Q3 2017, an estimated $41K.
  • Acrospire Investment Management first reported a position in Exact Sciences in Q1 2017 and held it in 2 quarters.
  • Acrospire Investment Management's Exact Sciences position peaked at $41K in Q2 2017.
  • 282 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.